Q3 FY26 standalone PAT Rs 378.7M, up 78% YoY; revenue up 22%

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

ARSSBL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.6%Reaction day

₹632.55

prior close

₹655.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%+3.0% vs market

Stockbroking & Allied peers, median of 37sector-0.3%+2.9% vs sector

On the reaction day the stock moved 3.0 pts more than Nifty Microcap 250 and 2.9 pts more than its Stockbroking & Allied peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.7

10m

-1.2

15m

-0.9

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.6-0.4+3.0-0.3+2.9

Next day

+3.7-1.7+5.4-1.3+5.1

-4.5-4.3-0.1-5.4+1.0

-5.9-5.1-0.8-5.9-0.0

-4.3-3.6-0.7-5.3+1.0

-6.8-5.7-1.1-6.7-0.1

-4.6-3.7-0.9-5.6+1.0

15d

-10.4+2.1-12.5-3.6-6.8

-15.9-0.1-15.8-7.5-8.4

-26.0-10.0-16.1-18.1-7.9

-9.0+2.2-11.2-7.1-1.9

UpDownMarket · Nifty Microcap 250Sector · Stockbroking & Allied peers, median of 37Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q3 FY26 standalone revenue rose 22% YoY to Rs 2,481M; PAT surged 78% to Rs 378.7M. For 9M FY26, revenue grew 5% to Rs 6,762M and PAT rose 5% to Rs 898M. Operating margin expanded sharply to 20.4% in Q3 vs 14% YoY. First reporting year post IPO; net proceeds of Rs 7,035M fully deployed for working capital and general purposes. Auditor R Kabra and Co LLP issued unmodified conclusion. Commercial paper rating A1 reaffirmed by CARE and assigned by Crisil.

Likely market impact

Strong Q3 beat with sharp PAT growth and margin expansion signals healthy broker momentum; positive read for shareholders.